The company will report earnings before the open on Jan. 29 Israel-based pharmaceutical giant Teva Pharmaceutical Industries Ltd ... As we prepare for a new administration to take the reins ...
will discuss new data presented for duvakitug (anti-TL1A) positive Phase 2b results at the 20th Annual Congress of Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug ...
Wilmington Savings Fund Society FSB acquired a new stake in Teva Pharmaceutical Industries during the third quarter worth about $50,000. Claro Advisors LLC bought a new position in Teva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results